AGAPE ATP CORPORATION (ATPC) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $100.00; Additional Paid in CapitalUSD $34.27M; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-247.64K.
- 2026-03-31: Common Stock, Value, IssuedUSD $100.00; Additional Paid in CapitalUSD $34.27M; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-28.13K.
- 2025-12-31: Common Stock, Value, IssuedUSD $100.00; Additional Paid in CapitalUSD $34.27M; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-14.69K.
- 2025-09-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $34.24M; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $12.07K.
AGAPE ATP CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Adjustments to Additional Paid in Capital, Stock Split MYR |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00 | $34.27M | (m) | $-247.64K | $-11.97M | $22.05M | $22.05M | (m) | 3 month · $49.74K | (m) |
| 2026-03-31 | $100.00 | $34.27M | (m) | $-28.13K | $-12.13M | $22.12M | $22.07M | (m) | (m) | (m) |
| 2025-12-31 | $100.00 | $34.27M | (m) | $-14.69K | $-11.80M | $22.46M | $22.43M | (m) | (m) | (m) |
| 2025-09-30 | $5.00K | $34.24M | (m) | $12.07K | $-11.42M | $22.83M | $22.80M | (m) | (m) | (m) |
| 2025-06-30 | $5.00K | $34.24M | (m) | $23.25K | $-10.83M | $23.43M | $23.41M | (m) | (m) | (m) |
| 2025-03-31 | $5.00K | $34.24M | (m) | $24.64K | $-10.22M | $24.05M | $24.03M | (m) | (m) | (m) |
| 2024-12-31 | $8.00 | $11.42M | (m) | $27.85K | $-9.52M | $1.93M | $1.93M | 0.00 | (m) | (m) |
| 2024-09-30 | $399.00 | $11.42M | (m) | $34.11K | $-8.71M | $2.75M | $2.76M | 0.00 | (m) | (m) |
| 2024-06-30 | $7.70K | $11.39M | (m) | $26.89K | $-8.20M | $3.22M | $3.25M | 0.00 | (m) | (m) |
| 2024-03-31 | $7.70K | $11.38M | (m) | $28.66K | $-7.76M | $3.66M | $3.68M | 0.00 | (m) | (m) |
| 2023-12-31 | $386.00 | $11.39M | $1.00 | $30.21K | $-7.05M | $4.37M | $4.38M | 6.76K | (m) | (m) |
| 2023-09-30 | $7.54K | $6.47M | (m) | $17.98K | $-6.07M | $423.10K | $432.03K | (m) | (m) | (m) |
| 2023-06-30 | $7.54K | $6.47M | (m) | $11.61K | $-5.75M | $743.76K | $750.65K | (m) | (m) | (m) |
| 2023-03-31 | $7.54K | $6.47M | (m) | $11.34K | $-5.37M | $1.12M | $1.13M | (m) | (m) | (m) |
| 2022-12-31 | $7.54K | $6.47M | (m) | $9.27K | $-4.95M | $1.54M | $1.56M | 0.00 | (m) | (m) |
| 2022-09-30 | $7.54K | $6.47M | (m) | $-31.00K | $-4.21M | $2.23M | $2.24M | (m) | (m) | (m) |
| 2022-06-30 | $7.54K | $6.47M | (m) | $20.22K | $-3.97M | $2.53M | $2.54M | (m) | (m) | 3 month · 600.00K |
| 2022-03-31 | $7.54K | $6.47M | (m) | $81.38K | $-3.56M | $3.00M | $3.00M | (m) | (m) | (m) |
| 2021-12-31 | $29.05K | $6.45M | (m) | $93.40K | $-3.26M | $3.31M | $3.31M | (m) | (m) | (m) |
| 2021-09-30 | $37.65K | $6.44M | (m) | $86.37K | $-2.28M | $4.28M | $4.28M | (m) | (m) | (m) |
| 2021-06-30 | $37.65K | $6.44M | (m) | $106.39K | $-1.71M | $4.87M | $4.87M | (m) | (m) | 3 month · 150.00K |
| 2021-03-31 | $37.65K | $6.44M | (m) | $142.73K | $-1.07M | $5.55M | $5.55M | (m) | (m) | (m) |
| 2020-12-31 | $37.65K | $6.44M | (m) | $181.02K | $-734.44K | $5.92M | $5.92M | (m) | (m) | (m) |
| 2020-09-30 | $37.65K | $6.44M | (m) | $100.55K | $-818.68K | $5.76M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $37.64K | $6.35M | (m) | $45.60K | $-1.23M | $5.20M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $37.63K | $5.29M | (m) | $17.55K | $-1.32M | $4.03M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $37.63K | $5.29M | (m) | $9.79K | $-1.09M | $4.25M | $4.25M | (m) | (m) | (m) |
| 2019-09-30 | $37.63K | $5.29M | (m) | $-3.39K | $-848.34K | $-4.48M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $37.63K | $5.29M | (m) | $-79.00 | $-750.28K | $4.58M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $37.63K | $5.29M | (m) | $4.58K | $-310.94K | $5.02M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $37.63K | $5.29M | (m) | $-1.29K | $-373.08K | $4.96M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $37.63K | $5.29M | (m) | $-1.29K | $-366.50K | $4.96M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $37.63K | $5.29M | (m) | $-1.29K | $-230.64K | $5.10M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $37.43K | $5.29M | (m) | $340.00 | $-302.38K | $5.03M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $37.18K | $2.80M | (m) | $3.74K | $-279.04K | $2.56M | (m) | (m) | (m) | (m) |
| 2017-09-30 | $37.13K | $2.37M | (m) | (m) | $-154.97K | $2.25M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $37.13K | $2.37M | (m) | (m) | $-100.36K | $2.30M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | $-24.99K | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |